|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1850 K STREET, NW |
Address2 | SUITE 650 |
City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Cambridge |
State | MA |
Zip Code | 02142 |
Country | USA |
|
5. Senate ID# 16054-12
|
||||||||
|
6. House ID# 302570000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Mary McGrane, Senior Vice President |
Date | 07/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S. 515, Patent Reform Act of 2009
H.R. 1260, Patent Reform Act of 2009
S. 610, Patent Reform Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
McGrane |
|
Senior Vice President |
|
Sara |
Froelich |
|
Vice President |
|
Kay |
Holcombe |
|
Senior Policy Advisor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 444, 340B Program Improvement and Integrity Act of 2009, 340B drug price expansion
ESRD "Bundling Issues" and ESRD Drug Reimbursement Issues
HCPCS Coding Decisions
Reimbursement for Part B Drugs Administered in Hospital Out-patient Departments, Dialysis Centers and Physician Offices
Physician Fee Schedule Payment Rates for Lab Tests
Medicaid Rebates
Implementation of MIPPA
H.R. 1699, Patient Access to Critical Lab Test
H.R. 1452, Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009
Reimbursement /Payment Laboratory Tests
H.R. 676, US National Health Care Act or the Expanded and Improved Medicare for All Act
Reimbursement for Clinical Lab Tests
Reimbursement for Medicare Part D Drugs
H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3590, Patient Protection & Affordable Health Care Act
H.R. 4872, Health Care and Education Reconciliation Act of 2010
H.R. 4851, Continuing Extension Act of 2010
H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010
H.R. 2847, Hiring Incentives to Restore Employment Act
Health Care Reform Implementation Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
McGrane |
|
Senior Vice President |
|
Sara |
Froelich |
|
Vice President |
|
Kay |
Holcombe |
|
Senior Policy Advisor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 3156, Neglected Disease Tax Credit Bill
H.R. 759, Food and Drug Administration Globalization Act of 2009
H.R. 3590, Patient Protection & Affordable Health Care Act
Treatment of Orphan Drugs Under 340B Expansion
H.R. 4872, Health Care and Education Reconciliation Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
McGrane |
|
Senior Vice President |
|
Sara |
Froelich |
|
Vice President |
|
Kay |
Holcombe |
|
Senior Policy Advisor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R. 1452, Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009
Reimbursement for Clinical Lab Services under Medicare
Excise Tax for Laboratory Services
H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3590, Patient Protection & Affordable Health Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
McGrane |
|
Senior Vice President |
|
Sara |
Froelich |
|
Vice President |
|
Kay |
Holcombe |
|
Senior Policy Advisor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 3156, Neglected Disease Tax Credit Bill
Excise Tax for Medical Devices
H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3590, Patient Protection & Affordable Health Care Act
H.R. 4872, Health Care and Education Reconciliation Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
McGrane |
|
Senior Vice President |
|
Sara |
Froelich |
|
Vice President |
|
Kay |
Holcombe |
|
Senior Policy Advisor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 4872, Health Care and Education Reconciliation Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
McGrane |
|
Senior Vice President |
|
Sara |
Froelich |
|
Vice President |
|
Kay |
Holcombe |
|
Senior Policy Advisor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |